Melbourne, Australia, October 6, 2025
Heidi, the fast-growing healthcare AI company, today announced the closing of a $65 million Series B funding round, led by Point72 Private Investments with participation from continuing investors Blackbird, Headline, and Latitude, the growth fund of Phoenix Court. This round values Heidi at $465 million and brings total funding to nearly $100 million.
The Series B funding will accelerate Heidi’s mission to build an AI Care Partner that sits alongside clinicians, expanding their capacity by automating tasks such as clinical documentation, evidence search, and follow-up communications. Research shows clinicians spend nearly as much time on administration as on patient care. In just 18 months, Heidi has returned more than 18 million hours to frontline clinicians by streamlining critical administrative tasks.
Dr Thomas Kelly, the CEO and co-founder of Heidi and former vascular surgical resident, said:
Dr Thomas Kelly, the CEO and co-founder of Heidi and former vascular surgical resident, said:
“It is untenable that healthcare demand continues to rise while clinical time continues to shrink. Building a sustainable healthcare system requires expanding clinical capacity without compromising clinician wellbeing or patient safety. That’s why I founded Heidi: to build an AI Care Partner that stands alongside clinicians, empowering them to deliver the care to which they have dedicated their lives.”
